Malaysia has approved the use of rivaroxaban, a
once-daily oral anticoagulant for reduction of stroke-risk in patients with
sustained irregular heart rhythm.
Malaysia has become the first
country in Asia and the third in the world to approve rivaroxaban for this
purpose, said Dr Axel Bouchon, general manager for Bayer HealthCare in
Malaysia, Singapore and Brunei.
He said National Pharmaceutical
Control Bureau of the Ministry of Health Malaysia gave the approval recently,
shortly after approvals by the United States and Ukraine.
In a statement here today,
Bouchon said the US-FDA recommends rivaroxaban for the prevention of stroke and
systemic embolism in patients with non-valvular atrial fibrillation (AF).
"AF-related stroke can be
prevented with proper diagnosis, treatment and management. With the approval,
Malaysian patients who are living with AF can be among the first in the world
to benefit from rivaroxaban, which also has potential to help reduce the
devastating burden that strokes have on patients and their families," he
added.
Datuk Dr Azhari Rosman,
consultant cardiologist with the National Heart Institute, said in the same
statement that approval of rivaroxaban offers physicians a new option to
effectively reduce stroke-risk in patients who are living with atrial
fibrillation and the continous threat of strokes.
An estimated 40,000 Malaysians
succumb to stroke each year, making it the third largest cause of death in
Malaysia, after heart disease and cancer, and also the most common cause of
severe disability, the statement said.
The Sun Daily
Business & Investment Opportunities
YourVietnamExpert is a division of Saigon Business Corporation Pte Ltd, Incorporated in Singapore since 1994. As Your Business Companion, we propose a range of services in Consulting, Investment and Management, focusing three main economic sectors: International PR; Healthcare & Wellness;and Tourism & Hospitality. We also propose Higher Education, as a bridge between educational structures and industries, by supporting international programs. Sign up with twitter to get news updates with @SaigonBusinessC. Thanks.
No comments:
Post a Comment